RAYMOND JAMES & ASSOCIATES - FLEXION THERAPEUTICS INC ownership

FLEXION THERAPEUTICS INC's ticker is FLXN and the CUSIP is 33938J106. A total of 104 filers reported holding FLEXION THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of FLEXION THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$2,713,000
-9.5%
444,705
+22.1%
0.00%
-33.3%
Q2 2021$2,997,000
+67.8%
364,176
+82.5%
0.00%
+50.0%
Q1 2021$1,786,000
-22.0%
199,581
+0.6%
0.00%
-33.3%
Q4 2020$2,289,000
+1.2%
198,373
-8.7%
0.00%0.0%
Q3 2020$2,262,000
-22.7%
217,327
-2.3%
0.00%
-25.0%
Q2 2020$2,926,000
+57.5%
222,546
-5.7%
0.00%
+33.3%
Q1 2020$1,858,000
-37.7%
236,054
+63.7%
0.00%
-25.0%
Q4 2019$2,984,000
+27.2%
144,177
-15.8%
0.00%
+33.3%
Q3 2019$2,346,000
-13.7%
171,167
-22.5%
0.00%
-25.0%
Q2 2019$2,717,000
+9.0%
220,899
+10.6%
0.00%0.0%
Q1 2019$2,492,000
+60.4%
199,715
+45.4%
0.00%
+33.3%
Q4 2018$1,554,000
-55.8%
137,316
-27.0%
0.00%
-40.0%
Q3 2018$3,518,000
-19.1%
188,003
+11.8%
0.01%
-28.6%
Q2 2018$4,346,000
-4.4%
168,115
-26.1%
0.01%
-12.5%
Q1 2018$4,546,000
-13.5%
227,441
-0.2%
0.01%
-20.0%
Q4 2017$5,253,000
+75.0%
228,000
+83.7%
0.01%
+66.7%
Q3 2017$3,001,000
+23.4%
124,128
+3.2%
0.01%
+20.0%
Q2 2017$2,431,000
+28.2%
120,245
+34.9%
0.01%
+25.0%
Q1 2017$1,896,000
+386.2%
89,110
+334.7%
0.00%
+300.0%
Q4 2016$390,00020,5000.00%
Other shareholders
FLEXION THERAPEUTICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Versant Venture Management, LLC 3,842,578$40,001,0007.32%
MILLER VALUE PARTNERS, LLC 5,274,439$54,907,0001.97%
Mesirow Financial Investment Management, Inc. 32,371$337,0001.44%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,068,580$11,124,0001.25%
Clearline Capital LP 399,159$4,155,0001.09%
CLOUGH CAPITAL PARTNERS L P 1,246,150$12,972,0000.93%
Novo Holdings A/S 1,403,370$14,609,0000.72%
SNOW CAPITAL MANAGEMENT LP 303,265$3,157,0000.63%
AMERICAN FINANCIAL GROUP INC 317,700$3,308,0000.46%
Granahan Investment Management 1,257,690$13,093,0000.44%
View complete list of FLEXION THERAPEUTICS INC shareholders